Zosano Pharma Corp. Company Profile (NASDAQ:ZSAN)

About Zosano Pharma Corp.

Zosano Pharma Corp. logoZosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability. The Company's short-wear-time transdermal patch consists of an array of titanium microneedles that is coated with its formulation of an approved drug and attached to an adhesive patch. When the patch is applied with its hand-held applicator, the microneedles painlessly penetrate the skin, resulting in rapid dissolution and absorption of the drug coating through the capillary bed. Its product candidates include ZP-Triptan, ZP-Glucagon and ZP-PTH. ZP-PTH is a formulation of teriparatide, a synthetic form of parathyroid hormone. ZP-Glucagon is a formulation of glucagon.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ZSAN
  • CUSIP:
Key Metrics:
  • Previous Close: $0.82
  • 50 Day Moving Average: $0.9830
  • 200 Day Moving Average: $1.6108
  • 52-Week Range: $0.66 - $4.43
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.72
  • P/E Growth: 0.0000
  • Market Cap: $9.90M
  • Outstanding Shares: 12,015,000
  • Beta: 0.24
Profitability:
  • Return on Equity: -134.77%
  • Return on Assets: -74.21%
Debt:
  • Current Ratio: 2.64%
  • Quick Ratio: 2.64%
Additional Links:
Companies Related to Zosano Pharma Corp.:

Analyst Ratings

Consensus Ratings for Zosano Pharma Corp. (NASDAQ:ZSAN) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $11.00 (1,235.44% upside)
Analysts' Ratings History for Zosano Pharma Corp. (NASDAQ:ZSAN)
Show:
DateFirmActionRatingPrice TargetDetails
8/11/2016Ladenburg ThalmannDowngradeBuy -> NeutralView Rating Details
11/11/2015Roth CapitalBoost Price TargetBuy$7.00 -> $11.00View Rating Details
(Data available from 9/29/2014 forward)

Earnings

Earnings History for Zosano Pharma Corp. (NASDAQ:ZSAN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/10/2016Q2($0.50)($0.54)ViewN/AView Earnings Details
5/12/2016Q1($0.56)($0.68)ViewListenView Earnings Details
3/29/2016Q4($0.67)($0.64)ViewListenView Earnings Details
11/9/2015Q315($0.61)($0.72)$380.00 millionViewN/AView Earnings Details
8/12/2015Q215($0.53)($0.63)$1.78 millionViewN/AView Earnings Details
3/25/2015($0.64)($1.10)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Zosano Pharma Corp. (NASDAQ:ZSAN)
Current Year EPS Consensus Estimate: $-2.3900 EPS
Next Year EPS Consensus Estimate: $-1.1500 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.54)($0.54)($0.54)
Q2 20161($0.52)($0.52)($0.52)
Q3 20161($0.63)($0.63)($0.63)
Q4 20161($0.61)($0.61)($0.61)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Zosano Pharma Corp. (NASDAQ:ZSAN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Zosano Pharma Corp. (NASDAQ:ZSAN)
Insider Ownership Percentage: 9.68%
Institutional Ownership Percentage: 35.89%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/16/2016Enterprise Associates 12 NewMajor ShareholderSell7,471$0.75$5,603.25View SEC Filing  
9/13/2016Enterprise Associates 12 NewMajor ShareholderSell10,000$0.74$7,400.00View SEC Filing  
8/29/2016M James BarrettMajor ShareholderSell50,000$1.01$50,500.00View SEC Filing  
8/24/2016Enterprise Associates 12 NewMajor ShareholderSell1,200$1.21$1,452.00View SEC Filing  
8/19/2016Donald J KellermanVPBuy15,920$1.32$21,014.40View SEC Filing  
8/19/2016Georgia ErbezCFOBuy47,750$1.32$63,030.00View SEC Filing  
8/19/2016John Peter WalkerDirectorBuy63,700$1.32$84,084.00View SEC Filing  
8/19/2016Konstantinos AlatarisCEOBuy127,389$1.32$168,153.48View SEC Filing  
7/21/2016Enterprise Associates 12 NewMajor ShareholderSell23,681$1.27$30,074.87View SEC Filing  
7/13/2016Enterprise Associates 12 NewMajor ShareholderSell13,382$1.20$16,058.40View SEC Filing  
1/30/2015Enterprise Associates 12 NewMajor ShareholderBuy23,457$11.00$258,027.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Zosano Pharma Corp. (NASDAQ:ZSAN)
DateHeadline
publicnow.com logoZosano Announces Inducement Grant for Georgia Erbez, Chief Business Officer (NASDAQ:ZSAN)
www.publicnow.com - September 9 at 7:52 PM
publicnow.com logoZosano Appoints Georgia Erbez as Chief Business Officer (NASDAQ:ZSAN)
www.publicnow.com - September 8 at 12:11 PM
News IconInvestor News: Investigation of Zosano Pharma Corp (NASDAQ:ZSAN) over potential Securities Laws Violations (NASDAQ:ZSAN)
www.groundreport.com - September 7 at 12:09 PM
sbwire.com logoInvestigation for Investors Who Lost Money by Investing in Shares of Zosano Pharma Corp (NASDAQ:ZSAN)
www.sbwire.com - September 1 at 8:14 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Shareholders of Zosano Pharma Corporation - ZSAN (NASDAQ:ZSAN)
finance.yahoo.com - September 1 at 11:39 AM
4-traders.com logoZosano Pharma Corp : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Investigation of Zosano Pharma Corporation (ZSAN) (NASDAQ:ZSAN)
www.4-traders.com - August 30 at 8:08 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Investigation of Zosano Pharma Corporation (ZSAN) (NASDAQ:ZSAN)
finance.yahoo.com - August 29 at 8:21 PM
News IconIMPORTANT INVESTOR NOTICE: Lundin Law PC Announces an Investigation of Zosano Pharma Corp. & Advises Investors With Losses in... (NASDAQ:ZSAN)
ih.advfn.com - August 27 at 5:06 AM
finance.yahoo.com logoIMPORTANT INVESTOR NOTICE: Lundin Law PC Announces an Investigation of Zosano Pharma Corporation and Advises Investors With Losses in Excess of $10,000 Contact the Firm (NASDAQ:ZSAN)
finance.yahoo.com - August 27 at 5:06 AM
finance.yahoo.com logoALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Zosano Pharma Corporation (NASDAQ:ZSAN)
finance.yahoo.com - August 26 at 7:59 PM
News IconDirector of Zosano Pharma Corporation (NASDAQ:ZSAN), Xanthopoulos Kleanthis G, buys 15,920 shares worth $21,014 (NASDAQ:ZSAN)
empowerednews.net - August 24 at 8:11 PM
finance.yahoo.com logoZosano Pharma Corp (ZSAN) President, CEO Konstantinos Alataris Bought $168,153 of Stocks (NASDAQ:ZSAN)
finance.yahoo.com - August 23 at 10:21 AM
streetinsider.com logoZosano Pharma (ZSAN) Prices Common Stock, Warrants Private Placement at $1.57/Unit (NASDAQ:ZSAN)
www.streetinsider.com - August 17 at 11:26 AM
finance.yahoo.com logo8:41 am Zosano Pharma enters securities purchase agreement to sell shares of its common stock and warrants to purchase shares of its common stock at a price of $1.57/unit in a private placement (NASDAQ:ZSAN)
finance.yahoo.com - August 16 at 11:47 AM
publicnow.com logoZosano Pharma Announces Pricing of Private Placement of Common Stock and Warrants (NASDAQ:ZSAN)
www.publicnow.com - August 16 at 11:47 AM
biz.yahoo.com logoZOSANO PHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements (NASDAQ:ZSAN)
biz.yahoo.com - August 16 at 11:47 AM
finance.yahoo.com logoIMPORTANT ZOSANO ALERT: Lundin Law PC Announces an Ongoing Investigation of Zosano Pharma Corporation and Advises Investors with Losses In Excess of $10,000 to Contact the Firm (NASDAQ:ZSAN)
finance.yahoo.com - August 12 at 8:35 PM
finance.yahoo.com logoLadenburg Thalmann Downgrades Zosano Pharma To Neutral On Financing Overhang, Market Uncertainty (NASDAQ:ZSAN)
finance.yahoo.com - August 11 at 11:55 AM
publicnow.com logoZosano Pharma Reports Second Quarter 2016 Financial Results (NASDAQ:ZSAN)
www.publicnow.com - August 10 at 9:11 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of an Investigation of Zosano Pharma Corporation (ZSAN) (NASDAQ:ZSAN)
finance.yahoo.com - August 4 at 11:44 AM
publicnow.com logoFirst Subject Treated in Zosano Pharma's Pivotal Efficacy Trial for M207 Patch for Acute Migraine (NASDAQ:ZSAN)
www.publicnow.com - July 25 at 8:48 AM
finance.yahoo.com logoFirst Subject Treated in Zosano Pharma’s Pivotal Efficacy Trial for M207 Patch for Acute Migraine (NASDAQ:ZSAN)
finance.yahoo.com - July 25 at 8:30 AM
4-traders.com logoZosano Pharma : Enterprise Associates 12 New Sells 23,681 Shares of Zosano Pharma Corp. Stock (NASDAQ:ZSAN)
www.4-traders.com - July 24 at 7:51 PM
globenewswire.com logoScott + Scott, LLP Announces Investigation of Zosano Pharma Corp (ZSAN), Encourages Investors With Losses to Contact Firm (NASDAQ:ZSAN)
globenewswire.com - July 11 at 8:16 PM
News IconStockholder Notice: Investigation of Zosano Pharma Corp (NASDAQ:ZSAN) announced (NASDAQ:ZSAN)
empowerednews.net - July 5 at 8:00 PM
News IconInvestor News: Investigation for Investors in shares of Zosano Pharma Corp (NASDAQ:ZSAN) announced (NASDAQ:ZSAN)
www.groundreport.com - June 29 at 8:21 PM
feeds.benzinga.com logo10 Biggest Mid-Day Gainers For Tuesday (NASDAQ:ZSAN)
feeds.benzinga.com - June 28 at 1:31 PM
finance.yahoo.com logoZOSANO ALERT: Lundin Law PC Announces an Investigation of Zosano Pharma Corporation and Advises Investors with Losses to Contact the Firm (NASDAQ:ZSAN)
finance.yahoo.com - June 23 at 1:39 PM
sbwire.com logoInvestigation for Investors in Shares of Zosano Pharma Corp (NASDAQ:ZSAN) Announced (NASDAQ:ZSAN)
www.sbwire.com - June 21 at 7:50 PM
nasdaq.com logoCERS Gets BARDA Funding, EPZM Abuzz, ZSAN Awaits Data In Q1 2017 (NASDAQ:ZSAN)
www.nasdaq.com - June 20 at 9:45 AM
streetinsider.com logoZosano Pharma (ZSAN) Announces Enrollment of First Subject in Trial for ZP-Triptan Patch Program to Treat Migraine (NASDAQ:ZSAN)
www.streetinsider.com - June 20 at 9:45 AM
seekingalpha.com logoZosano Pharma's pivotal study of ZP-Triptan patch for migraine underway (NASDAQ:ZSAN)
seekingalpha.com - June 17 at 11:08 AM
publicnow.com logoZosano Pharma Enrolls First Subject in Pivotal Clinical Trial for ZP-Triptan Patch Program for Treatment of Migraine (NASDAQ:ZSAN)
www.publicnow.com - June 17 at 10:19 AM
finance.yahoo.com logoZOSANO INVESTIGATION ALERT: Khang & Khang LLP Announces An Ongoing Investigation of Claims against Zosano Pharma Corporation And Encourages Investors With Losses to Contact the Firm (NASDAQ:ZSAN)
finance.yahoo.com - June 15 at 6:50 PM
finance.yahoo.com logoONGOING INVESTIGATION: Lundin Law PC Announces Investigation of Zosano Pharma Corporation and Advises Investors with Losses to Contact the Firm (NASDAQ:ZSAN)
finance.yahoo.com - June 14 at 1:52 PM
finance.yahoo.com logoEdited Transcript of ZSAN earnings conference call or presentation 12-May-16 8:30pm GMT (NASDAQ:ZSAN)
finance.yahoo.com - May 20 at 5:03 PM
finance.yahoo.com logoZOSANO PHARMA CORP Financials (NASDAQ:ZSAN)
finance.yahoo.com - May 20 at 1:04 PM
finance.yahoo.com logoINVESTIGATION ALERT: Khang & Khang LLP Announces An Ongoing Investigation of Claims against Zosano Pharma Corporation And Encourages Investors With Losses to Contact the Firm (NASDAQ:ZSAN)
finance.yahoo.com - May 17 at 12:20 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Zosano Pharma Corporation (ZSAN) (NASDAQ:ZSAN)
finance.yahoo.com - May 17 at 11:58 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Lundin Law PC Announces Investigation Of Zosano Pharma Corporation And Advises Investors With Losses To Contact the Firm (NASDAQ:ZSAN)
finance.yahoo.com - May 16 at 6:50 PM
publicnow.com logoZosano Pharma Reports First Quarter 2016 Financial Results (NASDAQ:ZSAN)
www.publicnow.com - May 12 at 5:27 PM
finance.yahoo.com logoINVESTOR ALERT: Investigation of Zosano Pharma Corporation Announced by the Law Firm Goldman Scarlato & Penny, P.C.; Investors Encouraged to Contact the Firm (NASDAQ:ZSAN)
finance.yahoo.com - May 12 at 4:59 PM
biz.yahoo.com logoZOSANO PHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi (NASDAQ:ZSAN)
biz.yahoo.com - May 12 at 4:14 PM
biz.yahoo.com logoQ1 2016 Zosano Pharma Corp Earnings Release - Time Not Supplied (NASDAQ:ZSAN)
biz.yahoo.com - May 12 at 7:07 AM
publicnow.com logoZosano Announces Appointment of John P. Walker as Chairman of the Board (NASDAQ:ZSAN)
www.publicnow.com - May 9 at 8:38 AM
publicnow.com logoZosano Pharma to Report First Quarter 2016 Financial Results (NASDAQ:ZSAN)
www.publicnow.com - May 2 at 4:30 PM
fxpips.com logoTrading Report: Gaps Up – Zosano Pharma (ZSAN), CafePress (PRSS), Ultra Clean (UCTT) (NASDAQ:ZSAN)
www.fxpips.com - February 26 at 2:35 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Violations of Federal Securities Laws by the Board of Zosano Pharma Corporation (NASDAQ:ZSAN)
finance.yahoo.com - January 21 at 11:40 AM
finance.yahoo.com logoRobbins Arroyo LLP Is Investigating the Officers and Directors of Zosano Pharma Corporation (ZSAN) on Behalf of Shareholders (NASDAQ:ZSAN)
finance.yahoo.com - January 20 at 4:19 PM
biz.yahoo.com logoZOSANO PHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements (NASDAQ:ZSAN)
biz.yahoo.com - January 7 at 5:13 PM

Social

Zosano Pharma Corp. (NASDAQ:ZSAN) Chart for Thursday, September, 29, 2016


Last Updated on 9/29/2016 by MarketBeat.com Staff